This is a news story, published by CNBC, that relates primarily to Noom news.
For more Noom news, you can click here:
more Noom newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
new weight loss product. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest weight loss drugs news, substantial medication discounts news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Digital health company NoomCNBC
•
75% Informative
Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $ 149 .
The treatment will feature compounded semaglutide, the same active ingredient in Novo Nordisk's blockbuster obesity and diabetes drugs Wegovy and Ozempic .
Noom is the latest in a string of digital health companies to offer compounded versions of the medications as a cheaper alternative for consumers.
And if users decide they are ready to move off the medication, they can chat with their clinician or tap "initiate taper" in their settings, Noom said. "I think there's a lot of folks who don't want to be on a medication for the rest of their lives, and in any event, people aren't doing that in the real world," Cook said. "Our goal is just not to sell more medications. It's to drive sustained weight loss outcomes.".
VR Score
69
Informative language
65
Neutral language
57
Article tone
informal
Language
English
Language complexity
46
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
1
Affiliate links
no affiliate links